| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.97M | $1.15M | - | |
| Dir | 521.7K | $305.7K | - | |
| COO | 401.8K | $235.4K | - | |
| CEO | 63.9K | $37.5K | - | |
| Dir | 28.4K | $16.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 80,646 | $0.31 | $25,000.26 | +127.6% | |
| Jan 3, 2023 | Equels Thomas K | CEO &President | Buy | 161,291 | $0.31 | $50,000.21 | +42.1% | |
| Jan 3, 2023 | Appelrouth Stewart | Director | Buy | 80,646 | $0.31 | $25,000.26 | +59.1% | |
| Jul 16, 2021 | Equels Thomas K. | CEO &President | Buy | 15,625 | $1.92 | $30,000.00 | +7.5% | |
| Feb 25, 2021 | Appelrouth Stewart | Director | Buy | 10,638 | $2.35 | $24,999.30 | +13.0% | |
| Feb 24, 2021 | Equels Thomas K. | CEO &President | Buy | 11,062 | $2.26 | $25,000.12 | +5.6% | |
| Dec 17, 2020 | Equels Thomas K. | CEO | Buy | 14,535 | $1.72 | $25,000.20 | +7.9% | |
| Sep 3, 2020 | Equels Thomas K. | CEO &President | Buy | 12,316 | $2.03 | $25,001.48 | +7.2% | |
| Aug 21, 2020 | Equels Thomas K. | CEO | Buy | 10,730 | $2.33 | $25,000.90 | +6.7% | |
| Jun 27, 2019 | Equels Thomas K. | Exec. Vice Chairman/ Ceo/ Pres. | Buy | 2,632 | $4.37 | $11,501.84 | +4.4% |